David MacNaughtan (Sagard Holdings)

Roy­al­ty Phar­ma gets more com­pe­ti­tion as a pri­vate eq­ui­ty firm launch­es $725M roy­al­ty-buy­ing fund

Pablo’s got some peers.

Twen­ty-five years af­ter Mex­i­can bil­lion­aire Pablo Legor­re­ta start­ed buy­ing up fu­ture roy­al­ties on ap­proved drugs — and eight months af­ter he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.